Skip to main content

Table 2 Patient demographic and clinical characteristics

From: A single centre retrospective study of systemic reactions to subcutaneous immunotherapy

Characteristic Patients with systemic reaction
Median age—yr 34
Age range—yr 8–60
Male patients, n (%) 19 (68.9)
Angiotensin converting enzyme inhibitor or angiotensin receptor blocker use, n (%) 0 (0)
Beta-blocker use, n (%) 0 (0)
Asthma, n (%) 11 (39.3)
Grade 1 reaction, n (%) 8 (28.6)
Grade 2 reaction, n (%) 9 (32.1)
Grade 3 reaction, n (%) 8 (28.6)
Grade 4 reaction, n (%) 3 (10.7)